0000899243-21-036424.txt : 20210917
0000899243-21-036424.hdr.sgml : 20210917
20210917164249
ACCESSION NUMBER: 0000899243-21-036424
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210917
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHEN ISAN
CENTRAL INDEX KEY: 0001586218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 211260966
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS, INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-17
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001586218
CHEN ISAN
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
1
0
0
0
Common Stock
2021-09-17
4
C
0
61444
A
192783
D
Series A Preferred Stock
2021-09-17
4
C
0
16366
0.00
D
Common Stock
42509
0
D
Series B Preferred Stock
2021-09-17
4
C
0
7290
0.00
D
Common Stock
18935
0
D
On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
Includes 37,105 shares subject to repurchase by us, which are subject to vesting.
/s/ John Healy, Attorney-in Fact
2021-09-17